Long-term generation of antiPCSK9 antibody using a nanoliposome-based vaccine delivery system-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long-term generation of antiPCSK9 antibody using a nanoliposome-based vaccine delivery system

Published:2019-04 Issue: Volume:283 Page:69-78
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Momtazi-Borojeni Amir Abbas,Jaafari Mahmoud Reza,Badiee Ali,Sahebkar Amirhossein

Funder

Mashhad University of Medical Sciences, Mashhad, Iran

National Institute for Medical Research Development

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference43 articles.

1. The PCSK9 decade thematic review series: new lipid and lipoprotein targets for the treatment of cardiometabolic diseases;Lambert;J. Lipid Res.,2012

2. Secreted PCSK9 downregulates low density lipoprotein receptor through receptor-mediated endocytosis;Qian;J. Lipid Res.,2007

3. Acid-dependent ligand dissociation and recycling of LDL receptor mediated by growth factor homology region;Davis;Nature,1986

4. Structure of the LDL receptor extracellular domain at endosomal pH;Rudenko;Science,2002

5. Deletion of two growth-factor repeats from the low-density-lipoprotein receptor accelerates its degradation;Van der Westhuyzen;Biochem. J.,1991

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid nanoparticle (LNP) mediated mRNA delivery in cardiovascular diseases: Advances in genome editing and CAR T cell therapy;Journal of Controlled Release;2024-08

2. Atherosclerosis and inflammation: therapeutic targets and ways of correction;The Clinician;2024-06-23

3. Targeting aging and age-related diseases with vaccines;Nature Aging;2024-04-15

4. Role of Treg cell subsets in cardiovascular disease pathogenesis and potential therapeutic targets;Frontiers in Immunology;2024-03-15

5. Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside;Signal Transduction and Targeted Therapy;2024-01-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3